# Zentek Ltd.

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/fi/companies/Zentek Ltd.).

## Overview

Zentek Ltd. is a materials and technology company focused on graphene-based products and advanced materials, including ZenGUARD™ air filtration technology and its Albany Graphite project in Northern Ontario. The company operates through a mix of intellectual property development, partner-led commercialization, and mineral resource development activities, with operations centered in Canada and a U.S. subsidiary structure.

## Products & services

• ZenGUARD™ enhanced air filters
• Coated filter media supply for HVAC and face masks
• Graphene-based technology licensing and transfer
• Albany Graphite project development
• Advanced materials and IP platform

- **ZenGUARD™ air filtration products** (30%) — Graphene-based air filter products designed to improve indoor air quality and reduce pressure drop.
- **Coated media supply** (15%) — Pre-coated filter media sold to partners for assembly into finished HVAC filters or masks.
- **Technology licensing** (35%) — Licensing and technology transfer arrangements for partner commercialization of Zentek IP.
- **Graphite project development** (15%) — Development of the Albany Graphite project and related technical and permitting work.
- **Advanced materials and R&D** (5%) — Research, validation, and patent-backed development of graphene-based and adjacent materials.

- ZenGUARD™ enhanced air filters
- Coated filter media supply for HVAC and face masks
- Graphene-based technology licensing and transfer
- Albany Graphite project development
- Advanced materials and IP platform

## Customers

Zentek sells to commercial partners, manufacturers, and potentially end users rather than a broad consumer base. In air filtration, buyers include HVAC and filter manufacturers, distributors, and institutional customers that need improved indoor air quality solutions. For the graphite and advanced materials platform, the economic buyers are industrial and technology partners that value patented material performance and supply reliability.

- **HVAC filter manufacturers** (primary) — They buy coated media or finished ZenGUARD-enhanced products to add air-quality performance to their own filter lines.
- **Commercial and institutional buildings** (primary) — They are the end-market users of enhanced filtration where energy efficiency and indoor air quality both matter.
- **Technology and industrial partners** (secondary) — They license Zentek IP or collaborate on commercialization, manufacturing, and market access.
- **Graphite and advanced materials developers** (secondary) — They engage with the Albany Graphite asset and related material development capabilities.

- HVAC filter manufacturers seeking coated media or finished products
- Commercial and institutional building operators focused on air quality
- Distributors and channel partners for filtration products
- Industrial and technology partners for licensing and transfer
- Graphite and materials customers seeking high-purity feedstock

## Geography

Zentek is anchored in Canada, with headquarters and core operations in Guelph, Ontario and its Albany Graphite project in Northern Ontario. The company also uses U.S.-based subsidiaries and partners for commercialization, manufacturing, and market entry, especially in the air filtration business. Its business model is shaped by regulatory and partner readiness in both Canada and the United States.

- Headquartered in Guelph, Ontario
- Albany Graphite project in Northern Ontario
- Canadian core operations and technical development
- U.S. subsidiary and U.S. manufacturing partners
- North American commercialization focus for filtration products

## Strategy

Zentek's strategy centers on monetizing patented graphene-based technology through licensing, technology transfer, and supply partnerships rather than building a heavy direct manufacturing footprint. The company is also advancing the Albany Graphite asset as a strategic materials platform while building regulatory and commercial pathways for ZenGUARD in priority markets. These priorities reflect a focus on scalable commercialization, intellectual property protection, and partner-enabled market entry.

- **Partner-led commercialization** (short-term) — Licensing and supply partnerships allow broader market reach with limited capital intensity.
- **Regulatory pathway execution** (short-term) — Air filtration products require approvals and registrations before market expansion.
- **IP portfolio expansion** (medium-term) — Patent protection supports monetization, partner negotiations, and geographic expansion.
- **Albany Graphite development** (medium-term) — The graphite asset provides a second strategic platform beyond filtration technologies.

- Use licensing to generate recurring, partner-led commercialization revenue
- Advance ZenGUARD through regulatory clearance and market validation
- Expand through manufacturing and distribution partners rather than capex-heavy buildout
- Protect and extend IP through patents in key jurisdictions
- Develop Albany Graphite as a longer-term materials asset

## Risks

Zentek's commercialization depends on regulatory approvals, partner execution, and adoption of new filtration technologies, which can delay or limit revenue conversion. The company also faces development risk in its graphite asset and the typical risks of a small, innovation-driven materials company, including scale-up, IP enforcement, and reliance on a narrow product set. Listing and market-structure events are secondary to the business but can affect trading access and investor perception.

- **Regulatory clearance risk** [high] — ZenGUARD commercialization depends on approvals such as EPA registration and other market-specific requirements.
- **Partner dependency** [high] — The licensing and supply model relies on third parties for manufacturing, distribution, and market access.
- **Commercial adoption risk** [medium] — Customers may not adopt enhanced filters if performance, pricing, or energy savings are not compelling.
- **Project development risk** [high] — Albany Graphite remains a development-stage asset subject to technical, permitting, and funding risk.

- Regulatory approvals may delay or block market entry for ZenGUARD
- Partner execution risk can limit commercialization and supply scale
- Product adoption risk if customers resist new filter technology
- Graphite project development may require more time and capital
- Small-company IP and scale-up risks are concentrated in a few assets

## Accounting

Zentek's accounting is shaped by development-stage judgments around inventories, receivables, and the measurement of new business arrangements. The company also highlights future IFRS 18 disclosure changes, while the key analytical issue remains how costs, inventory valuation, and credit loss assumptions evolve as commercialization progresses. For investors, the timing of revenue recognition and any write-downs or provisions can materially affect reported results in a company with limited recurring revenue.

- **Inventory valuation** — Write-downs could affect margins and asset values if commercialization is delayed.
- **Expected credit loss allowance** — Provision changes can affect earnings when partner payments slow or default risk rises.
- **Revenue recognition timing** — Quarterly results may be volatile depending on contract milestones and shipments.
- **IFRS 18 presentation** — Comparability across periods and peers may change, even if underlying economics do not.

- Inventory valuation depends on lower of cost and net realizable value
- Expected credit loss allowances affect receivables and bad-debt expense
- Commercialization timing affects when product and licensing revenue is recognized
- Development-stage estimates may drive asset carrying values
- IFRS 18 will change presentation and disclosure, not recognition

---

*Last updated: 2026-09-28T12:18:50.038729+00:00*